The story has been updated with comments from Danaher's second-quarter earnings conference call.

NEW YORK (GenomeWeb News) – Danaher today reported a 4 percent year-over-year increase in revenues for the second quarter, while Life Sciences and Diagnostics revenues rose nearly 6 percent.

For the three months ended June 28, the Washington, DC-based conglomerate pulled in total revenues of $4.74 billion, up from $4.55 billion, topping the consensus Wall Street estimate of $4.72 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.